CPhI Announces Exhibitors' Latest Product News and Awards Finalists Ahead of Show

AsiaNet 54661

AMSTERDAM, Oct. 16 /PRN=KYODO JBN/ --

    - Novel nanonization technology enhances API solubility

    Chris Kilbee - Group Director Pharma, commenting on the announcements: "The

new products and award finalists are showcasing some remarkable technologies

that are driving innovation across the pharma sector and developing tomorrow's

drugs today."

    CPhI Pharma Award Finalists

    Best Innovation in Process Development

    - API Corporation: A novel and practical synthesis of highly functionalized

pharmaceuticals through C-H activation

    - Bachem: Pioneering breakthrough in the chemical synthesis of Interferon

beta-1a

    - Codexis: Enzymes for Green and Scalable Biocatalytic Oxidations

    Best Innovation in Formulation

    - Bitop: Ectoin(R) - a new natural ingredient with proven efficacy

    - Camurus: FluidCrystal(R) Injection depot

    - EmulTech: Microfluidic platform for controlled development

    Best Innovation in Packaging

    - E-Pharma Trento: E-PHARMA TRENTO SpA

    - Doctor Pack India: MAGIC CAP

    - Neutroplast: Vaginal applicator

    CPhI has today released its CPhI Pharma Awards finalists and some of the

new product announcements of its exhibitors ahead of CPhI Worldwide

[http://www.cphi.com ] 2013- featuring products and services ranging from

nanonization of APIs to sterile water-for-injection solutions. The product

announcement comes prior to the conference in Frankfurt (taking place 22-24

October at Messe Frankfurt), allowing attendees to maximise on the latest

innovations seen across the pharmaceutical industry before the show.

Additionally, you will also be able to hear from the awards' finalists during

their individual sessions at the Speaker's Corners

[http://www.cphi.com/europe/networking/cphi-speakers-corner ].

    (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

    Blank canvas offered at CPhI

    In contrast to CMOs traditionally offering fixed equipment capabilities,

SCM Pharma will be attending CPhI to offer pharmaceutical companies the

opportunity to design their clinical and contract manufacturing projects from a

'blank' canvas. The CMO, which specialises in the sterile manufacturing of drug

products, is offering cleanroom space at their new 26k sq. ft. site, allowing

customers to design their own projects based on their specific manufacturing

requirements. SCM Pharma's new site houses cutting-edge technology for aseptic

processing and terminal sterilisation capabilities, which will facilitate the

handling of highly potent, flammable and toxic products, along with controlled

drugs. With space for late stage and commercial scale projects, the CPhI

exhibitor is able to work alongside companies with more complex needs in

developing novel processes within, for example, unusual drug dosage forms and

smaller fill volumes.

    API technology solves solubility issues

    As a key formulations issue, poor API solubility has proved to be a

significant challenge within the pharmaceutical industry. However, NETZSCH will

be present at CPhI Worldwide, providing the latest solution with their agitator

bead mill DeltaVita(R). The DeltaVita(R) features a range of models, from small

laboratory- to production-size machines, all having been specially designed to

effectively enhance API solubility and, in turn, improve efficacy. By enabling

users to consistently generate particle sizes of below 100 nanometers, the

technology results in APIs with increased surface area, solubility and

bioavailability. Nanonization provides distinguished advantages including a

more targeted delivery of genes and vaccines. The increased bioavailability

also means that the amount of API required will be sufficiently reduced,

bearing multiple advantages including cost-efficiency, reduced risk and fewer

side effects of the finished product. Attendees at CPhI Worldwide will be able

to visit NETZSCH to discover the DeltaVita(R) series which provides an

advanced, scalable and reproducible product offering.

    Vetter extends filling capabilities backed by five years of data

    Further, supported by five years of stability data, Vetter will be

showcasing their sterile water-for-injection (sWFI) solution. The CDMO has

collated substantial data and adopted a bracketing concept to offer a filling

service for high-quality sWFI syringes, creating a longer shelf life for drugs,

and providing high flexibility when defining the required filling volume.

    Drugs are often lyophilized in order to reduce sensitivity to environmental

factors - this process ensures that drugs maintain a longer shelf life.

However, the drug must be returned to its original state by being dissolved in

a solvent to allow for treatment to a patient and it is Vetter's unparalleled

solution that facilitates safe and simple handling of this process. The

intelligent filling system is able to load the exact amount of solvent required

by a customer, to generate the correct dosage. Further benefiting customers,

Vetter's syringes are fully equipped with effective protection features,

including a tamper-evident closure, to provide ultimate product security. The

company has the capability to manufacture batches of up to 120,000 / 140,000

pieces and is ICH compliant - with documentation already existing for the USA,

Europe and Japan for customers looking to break into international markets.

    "An ever greater number of manufacturers are looking for options to enable

a safe and simple administration of lyophilized drugs. Our filling service for

WFI syringes represents a reliable and patient-friendly solution offering our

customers high flexibility due to Vetter's bracketing concept, and fast

time-to-market by using the ready-to-submit documents. In addition to documents

for approval in the USA and Europe, we also have all the necessary

documentation for Japan available for pharmaceutical and biotech firms, which

can considerably abridge the approval process." - Peter Soelkner, Managing

Director of Vetter.

    Grga & Melita offering hi-spec laboratory furniture solutions

    Croatian-based company Grga & Melita will be bringing 20 years of

experience in producing high-spec laboratory furniture to CPhI. Their latest

GIM lab laboratory furniture has been manufactured in accordance with the

highest European standards by a team of experienced designers and lab

specialists.

    Grga & Melita offer tailor made solutions for products including fume

hoods, laboratory sinks and work benches, whilst also offering a wife range of

safety cabinets for storage of acids, lyses, poisons, flammables and compressed

gas cylinders. By providing unique construction solutions and an individual

approach, the GIM lab laboratory furniture is distinctive within the market.

    CPhI is hosting the latest products and services offered by companies

across the pharmaceutical industry from 22 - 24 October with further exhibitors

announcing their latest news and innovations at the press conference taking

place across the entire three days.

    Chris Kilbee - Group Director Pharma, commenting on the announcements: "We

are delighted to share the latest services on offer from exhibiting companies

at CPhI Worldwide. We have witnessed an array of novel products, clearly

showcasing the extensive and committed innovations across the pharmaceutical

sector. By providing this platform, we have given the industry the opportunity

to see what is on offer ahead of the show to allow them to further maximise

their time at the event."

    Notes to editors

    About CPhI

    CPhI drives growth and innovation at every step of the global

pharmaceutical supply chain from drug discovery to finished dosage. Through

exhibitions, conferences and online communities, CPhI brings together more than

100,000 pharmaceutical professionals each year to network, identify business

opportunities and expand the global market. CPhI hosts events in Europe, China,

India, Japan, Southeast Asia, Russia and South America co-located with ICSE for

contract services, P-MEC for machinery, equipment & technology, InnoPack for

pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer

& supplier directory at CPhI-Online.com and hosts a global community with news

and analysis at PharmaEvolution.com.

    For more information visit: http://www.cphi.com

    The UBM Live annual schedule of Pharmaceutical events also includes CPhI

Worldwide, ICSE, P-MEC Europe and InnoPack (22-24 October, 2013 at Messe

Frankfurt, Germany); CPhI and P-MEC India (3-5 December, 2013 at the Bombay

Exhibition Centre in Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan

(9-11 April, 2014 in Tokyo); CPhI Russia and IPhEB (16-17 April, 2014 in St

Petersburg, Russia); CPhI, P-MEC and Innopack South East Asia (20-22 May, 2014

in Jakarta, Indonesia); CPhI Istanbul (4-6 June, 2014, Turkey) and CPhI, Hi and

Fi, ICSE, P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC, Shanghai,

China).

    About UBM Live

    UBM Live connects people and creates opportunities for companies across

five continents to develop new business, meet customers, launch new products,

promote their brands, and expand their market. Through premier brands such as

TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete

Show, and many others, UBM Live exhibitions, conferences, awards programs,

publications, Websites, and training and certification programs are an integral

part of the marketing plans of companies across more than 20 industry sectors.

    For media enquiries, please contact:

    Alex Heeley or Tristan Jervis

    De Facto Communications

    T: +44(0)207-203-6745 / 6740

    E: a.heeley@defacto.com / t.jervis@defacto.com

Source: UBM Live